ChemoCentryx
CCXI
#3578
Rank
A$5.64 B
Marketcap
A$78.55
Share price
0.00%
Change (1 day)
30.47%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI.defunct)

Last known market cap: A$5.64 Billion

On November 25, 2022 ChemoCentryx had a market cap of A$5.64 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022A$5.49 B56.22%
2021A$3.51 B-36.89%
2020A$5.57 B63.79%
2019A$3.40 B333.76%
2018A$0.78 B111.06%
2017A$0.37 B-24.27%
2016A$0.49 B-0.11%
2015A$0.49 B35.5%
2014A$0.36 B30.24%
2013A$0.27 B-27.26%
2012A$0.38 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$983.68 B 17,313.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$235.95 B 4,076.83%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$764.30 B 13,429.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$356.00 B 6,202.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$55.74 B 886.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$498.03 B 8,716.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$181.58 B 3,114.47%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$144.63 B 2,460.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$69.15 B 1,124.21%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel